Low PSA radiographic disease progression on C11-choline PET.

Journal: BJUI compass
Published Date: Oct 25, 2023

Abstract

BACKGROUND: For men with prostate cancer, radiographic progression may occur without a concordant rise in prostate-specific antigen (PSA). Our study aimed to assess the prevalence of radiographic progression using C-11 choline positron emission tomography (PET) imaging in patients achieving ultra-low PSA values and to evaluate clinical outcomes in this patient population.

Authors

  • Ahmed M Mahmoud
    Department of Urology Mayo Clinic Rochester Minnesota USA.
  • Mohamed E Ahmed
    Department of Urology Mayo Clinic Rochester Minnesota USA.
  • A Tuba Kendi
    Department of Radiology, Division of Nuclear Medicine Mayo Clinic Rochester Minnesota USA.
  • Matthew Thorpe
    Department of Radiology, Division of Nuclear Medicine Mayo Clinic Rochester Minnesota USA.
  • Geoffrey B Johnson
    Department of Radiology, Division of Nuclear Medicine Mayo Clinic Rochester Minnesota USA.
  • Irbaz Bin Riaz
    Department of Medical Oncology Mayo Clinic Scottsdale Arizona USA.
  • Jacob J Orme
    Department of Medical Oncology Mayo Clinic Rochester Minnesota USA.
  • Eugene D Kwon
    Department of Urology Mayo Clinic Rochester Minnesota USA.
  • Jack R Andrews
    Department of Urology Mayo Clinic Arizona Phoenix Arizona USA.
  • Daniel S Childs
    Department of Medical Oncology Mayo Clinic Rochester Minnesota USA.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals